Literature DB >> 3508562

Tissue tolerance of intramuscular injectables and plasma enzyme activities in rats.

C Surber1, H Sucker.   

Abstract

The local tissue damage after intramuscular injection caused by various commercially available injection solutions was determined in the albino rat, by measuring plasma activities of creatine phosphokinase, aspartate aminotransferase, and lactic dehydrogenase, the tissue activity of creatine phosphokinase, and macroscopic changes in the muscle at the injection site (gastrocnemius muscle). The plasma enzyme activities were determined 2, 6, 18, and 28 hr after the injection. After 28 hr the animals were sacrificed for macroscopic inspection of the injection site and for the determination of tissue enzyme activity. The tissue injury caused by the test substances correlated well with the elevated creatine phosphokinase activity (2 hr). The elevations of aspartate aminotransferase (18 hr) and lactate dehydrogenase (2 hr) activity as well as the loss of tissue creatine phosphokinase activity were less indicative of differences between test preparations. The i.p. administration of some of the test preparations caused increased enzyme activity without muscle damage, which could interfere with the test results. The creatine phosphokinase determination indicates the damage occurring immediately after the administration of the test solution, and the macroscopic inspection offers the possibility to obtain some information on the evolution of the muscular lesion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508562     DOI: 10.1023/a:1016427605545

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  The parenteral toxicity of clindamycin 2-phosphate in laboratory animals.

Authors:  J E Gray; R N Weaver; J Moran; E S Feenstra
Journal:  Toxicol Appl Pharmacol       Date:  1974-02       Impact factor: 4.219

2.  Studies on quantitative morphology. II. A stereological method for examination of local tissue injury following intramuscular injection.

Authors:  O Löw; G Machnik; G Simon; H Schicketanz
Journal:  Exp Pathol (Jena)       Date:  1973

3.  Chlorpromazine-induced hypothermia and increased plasma creatine phosphokinase activity.

Authors:  H Meltzer
Journal:  Biochem Pharmacol       Date:  1971-08       Impact factor: 5.858

4.  Clinical significance of enzyme activity measurements.

Authors:  J H Wilkinson
Journal:  Clin Chem       Date:  1970-11       Impact factor: 8.327

5.  [Intramuscular injections and activity of serum creatine phosphokinase. Histopathological study in animal experiments].

Authors:  H O Gloor; C Vorburger; J Schädelin
Journal:  Schweiz Med Wochenschr       Date:  1977-07-09

6.  Intramuscular or intralipomatous injections?

Authors:  W P Cockshott; G T Thompson; L J Howlett; E T Seeley
Journal:  N Engl J Med       Date:  1982-08-05       Impact factor: 91.245

7.  Studies on the absorption of practically water-insoluble drugs following injection. I. Intramuscular absorption from water-immiscible oil solutions in rats.

Authors:  K Hirano; T Ichihashi; H Yamada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-02       Impact factor: 1.645

8.  The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity.

Authors:  O Svendsen; F Rasmussen; P Nielsen; E Steiness
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-05

9.  Morphologic quantification of muscular lesions after injections of aqueous solutions.

Authors:  K F Benitz; G Dambach
Journal:  Arzneimittelforschung       Date:  1966-05

10.  A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs.

Authors:  E Steiness; F Rasmussen; O Svendsen; P Nielsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-05
View more
  4 in total

1.  [Changes in creatine kinase activity in serum following intramuscular injection].

Authors:  C Surber; U C Dubach; I Forgò
Journal:  Klin Wochenschr       Date:  1988-02-01

2.  Predicting injection site muscle damage. I: Evaluation of immediate release parenteral formulations in animal models.

Authors:  S C Sutton; L A Evans; M T Rinaldi; K A Norton
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

3.  In vitro-in vivo myotoxicity of intramuscular liposomal formulations.

Authors:  S A al-Suwayeh; I R Tebbett; D Wielbo; G A Brazeau
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

4.  An in vitro model to evaluate muscle damage following intramuscular injections.

Authors:  G A Brazeau; H L Fung
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.